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Abstract Spectral karyotyping is a novel technique for
chromosome analysis that has been developed based on the
approach of the ﬂuorescence in situ hybridization tech-
nique. Spectral karyotyping makes it feasible to diagnose a
variety of diseases, because of its technology in painting
each of the 24 human chromosomes with different colors.
In recent years, it has become possible to adopt the usage
of spectral karyotyping for research in general clinical
practice, and its usability has attracted particular attention
in the diagnosis of different diseases. In this review, we
will explain the principle of the spectral karyotyping, as
well as its speciﬁcity and limitation in detecting the genetic
defects within clinical application by presenting two case
reports.
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Introduction
The ﬁrst report of human chromosomes was made in 1882
by Flemming, in which 22–28 chromosomes in the divid-
ing cells of the corneal epithelium were described [1].
Forty years later, Painter reported that the number of
human chromosomes was 48 and that sex was determined
according to the presence or absence of the Y chromosome
[1]. It was not until the report of ‘‘2n = 46’’ was made in
1956 by Tjio and Levan that the nature of human chro-
mosomes was further established [1]. Following this report,
the relationships between various congenital disorders and
chromosomal abnormalities have been revealed one after
another. In 1959, Lejeune et al. [2] demonstrated that
Down syndrome is caused by the presence of an extra
chromosome 21, i.e., trisomy [3]. This ﬁnding of chro-
mosome 21-trisomy was a turning point in the subsequent
discovery of several other trisomy syndromes, including
chromosomes 18 [4, 5], 13 [6], 8 [7], and 22 [8, 9]. Besides
the chromosomal number aberrations, abnormalities asso-
ciated with sex chromosomes, viz., Turner syndrome [10]
and Klinefelter syndrome [11] and other chromosomes
[5, 12] have been reported.
An increased understanding of malignant diseases in the
1960s and the advent of better cell culture methods
including a method of culturing peripheral blood [13] led to
the ﬁrst discovery of chromosomal abnormalities in
malignant tumors, the Ph
1 chromosome, which is speciﬁc
to chronic myelogenous leukemia [14]. Genetic analysis
studies, represented by the Human Genomic Project [15],
led to the application of modern genetics tools in research
in biological phenomena such as the development, evolu-
tion, and aging, as well as abnormal cellular differentiation
including cancers.
Therefore, in the course of studying human chromo-
somes for more than a century, many new techniques have
been developed for chromosome testing. In 1971,
Caspersson, et al. [16] developed Q-staining using quina-
crine mustard, a ﬂuorescent dye that binds to DNA, which
was instrumental in the discovery that chromosomes have
banding patterns (stripes). Later, improved staining tech-
niques, including R-, T-, C-, and G-staining, have
appeared. The analysis of the band has further advanced
and now it has been developed into high-resolution chro-
mosome banding [17]. Furthermore, along with the
development of the ﬂuorescent in situ hybridization (FISH)
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some using ﬂuorescent labeled probe, it has become pos-
sible to identify chromosomal microdeletion and structural
abnormalities such as the extra portion of a chromosome
and a marker chromosome. FISH has also been used in
diagnosing abnormalities, caused by chromosomal aneu-
ploidy—which are difﬁcult to detect via conventional test
methods.
Comparative genomic hybridization (CGH) [19] and
spectral karyotyping (SKY) [20], which are based on the
FISH technique, are relatively recent and improved tech-
niques of chromosomal analysis. SKY as described here
refers to the multicolor-FISH technique, which makes it
possible to identify 24 human chromosomes via single
hybridization and then to stain them with different colors.
In this article, the analysis of chromosomal abnormalities
using the SKY technique and its limitation for detection
will be discussed.
Principle of SKY
Two techniques are used as the basic principles of FISH:
chromosome painting and multicolor ﬂuorescence. The
former is a technique of drawing an entire image of certain
chromosome by using ﬂuorescent signals. The latter is a
technique of drawing images of several hybridization sig-
nals with different ﬂorescent dyes. Combining these two
techniques, in 1996, the SKY technique was developed by
Schrock et al. [20].
In SKY, the color emission of chromosomes is deter-
mined by the combination of painting probes and (ﬂuo-
rescent dyes). In this technique, new colors can be
developed by extracting a pair of different ﬂuorescent dyes
from among the ﬁve types of ﬂuorescent dyes, spectrum
orange, Texas red, Cy5, spectrum green, Cy5.5, and mixing
each pair together. Thus, it is theoretically possible to
create 2
N-1 number of colors from N types of ﬂuorescent
dyes. Therefore, 31 types of colors can be created from ﬁve
types of ﬂuorescent dyes. In reality, however, because
some ﬂuorescence has a wavelength close to that within the
infrared spectrum, a two-dimensional imaging spectros-
copy system (e.g., the Spectral Bio-Imaging System
SD-200, Applied Spectral Imaging Ltd. Israel) needs to be
used to process spectral images so that 24 macroscopically
distinguishable colors (Table 1) can be created.
The amount of samples required for the test is 3.0 ml of
heparin-treated blood in the case of chromosome testing for
regular congenital abnormalities, and 1.0 ml of bone mar-
row ﬂuid and 5.0 ml of blood in the case of blood disor-
ders. Currently, no standardized method is available
for describing chromosome karyotypes based on SKY
analysis.
Characteristics of SKY in Clinical Application
When a chromosome in which the origin cannot be iden-
tiﬁed or the structural abnormality of a partial copy of a
chromosome is observed with G-banding, the SKY tech-
nique makes it possible to recognize each chromosome
with different color tones. Furthermore, when cells are
cultured under conditions in which the image acquisition of
cell division is difﬁcult, SKY enables bleaching and
staining of the specimen after the images of division have
been veriﬁed.
SKY provides the advantage of easy visual interpreta-
tion when analyzing results, but it is not possible to eval-
uate structural abnormalities, such as inversion, deletion,
insertion, and duplication in the same chromosome,
because these are shown with the same color. Also, neither
the Q-positive segment nor the satellite region of the long
arm of the Y chromosome near the centromere can be
detected. The resolution limit of detection is approximately
1–2 Mb, similar to conventional chromosome painting
techniques, and minor structural abnormalities of less than
1 band cannot be detected. Therefore, in order to verify
the site of chromosomal breakage, it is usually necessary to
use SKY beforehand in combination with G-banding or
Table 1 Combination of ﬂuo-
rescent dyes (painting probes) in
a chromosome analysis using
SKY
A spectrum orange, B Texas red,
C Cy5, D spectrum green,
E Cy5.5
Chromosome Painting probes
1 BCD
2E
3 ACDE
4C D
5 ABDE
6 BCDE
7B C
8D
9 ADE
10 CE
11 ACD
12 BE
13 AD
14 B
15 ABC
16 BD
17 C
18 ABD
19 AC
20 A
21 DE
22 ABCE
XA E
Y CDE
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123high-resolution chromosome banding, instead of using SKY
alone to macroscopically observe the banding patterns.
Furthermore, SKY provides the following notable
advantages. Conventionally, when a chromosome of
unknown origin is noticed in a child suffering with some
abnormality, a chromosome analysis is performed on both
parents in order to make a deﬁnitive diagnosis of the
chromosome in question. If a balanced structural abnor-
mality is detected in the chromosome of either of the par-
ents, then it is deﬁnitively diagnosed as the origin of such a
structural abnormality. Conventionally, macroscopic eval-
uation would be performed based on the banding patterns,
in case the informed consent for participation in the
karyotype test cannot be obtained from the parents, and in
the case of de novo translocation. In such cases, SKY has
the advantage of being capable of readily clarifying the
chromosome of unknown origin without performing kary-
otyping of the parents, and also can reveal if one of the
parents is a carrier of a balanced structural abnormality.
This advantage of SKY is very useful in the clinical practice
of genetic counseling [9]. Refer to Table 2 for the indica-
tions of evaluation using SKY when structural chromo-
somal abnormalities are actually found via G-banding.
Case and Review
In this section, two cases in which SKY can be used are
presented, and the beneﬁts and limitations of this technique
are discussed. We employed the application of 24-color
SKY probes [Applied Spectral Imaging (ASI), Inc., ASI,
Carlsbad, CA], skypaint
TM
hybridization and detection
protocol, SRL Inc., Tokyo, Japan.
Case 1: Trisomy 11/22
The results of chromosome analysis on Trisomy 11/22
using SKY are shown in Fig. 1 [8, 9]. SKY was performed
after an extra marker chromosome was detected in group G
chromosomes via G-banding and the results showed the
trisomy of chromosome 22. One of the extra chromosomes
was distinguished by two colors, and it was deduced to be a
derivative chromosome [der(22)], likely resulting from the
reciprocal translocation in which the long arms of chro-
mosome 11 (q23.3) and chromosome 22 (q11.2) were the
breakpoints. The karyotype of this case is described as
?der(22)t(11:22)(q23.3;q11.2). Therefore, SKY is one of
the most effective approaches at present for the identiﬁ-
cation of an extra chromosome of unknown origin. With
the use of SKY technique, it was possible to make a
deﬁnitive diagnosis of trisomy 11/22 in the child without
performing any chromosome testing on the parents, i.e.,
without examining the possibility of structural abnormali-
ties that would have been inherited from either one of the
parents. This is signiﬁcant in the clinical practice of genetic
counseling for parents to maintain their relationship.
Case 2: 13q-Syndrome
The results of the chromosome analysis of 13q-syndrome
using SKY (Fig. 2) indicate structural abnormalities in
chromosomes 2, 4, and 13 [12, 21]. For chromosomes 2
and 4, the reciprocal translocation t(2;4) with breakpoints
on the long arm of chromosome 2 (q24.2) and the short arm
of chromosome 4 (p14) can be readily distinguished. This
t(2;4), however, may involve [inv(4)(p15.1p15.32)], which
is a paracentric inversion with breakpoints at p15.1 and
Table 2 Usability when analyzing abnormalities that have been found via G-banding by using SKY
Result of G-banding Karyotype Supplementary note on SKY Usability of SKY
Accessory chromosome add Identiﬁes the derivative chromosome of an extra portion
a
Derivative chromosome der Identiﬁes the related chromosomes
a
Insertion ins Identiﬁes the derivative chromosome of insertion fragment
a
A complicated translocation Identiﬁes the related chromosomes
a
Genetic ampliﬁcation dimin/hsr Identiﬁes the derivative chromosome of homogeneous staining region
a
Duplication? ?dup Identiﬁes any duplication
a
Reciprocal translocation t Same analysis level of G-banding
b
Inversion inv Difﬁcult to make an analysis that is better than G-banding
c
Deletion del Difﬁcult to make an analysis that is better than G-banding
c
Numerical aberrations ?/- Difﬁcult to make an analysis that is better than G-banding
c
Unknown of derivative mar Identiﬁes a derivative chromosome within the limitations of sensitivity
c
Cryptic translocation Detects a derivative chromosome within the limitations of sensitivity
c
a The usability of SKY is considered to be high
b SKY can be used for analysis, but it cannot be expected to have better analysis results than those of G-banding
c Some cases cannot be detected using SKY
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123p15.32 in the short arm part of chromosome 4 that has been
translocated to chromosome 2, and this necessitates a
veriﬁcation via high-resolution chromosome banding.
Inversions occurring in the same chromosome are not
distinguished with color, so it is impossible to make a
deﬁnitive diagnosis by using SKY. Thus in this case,
testing of the parents’ chromosomes via high-resolution
chromosome banding is necessary for further detailed
diagnosis.
For chromosome 13, it is possible to diagnose the occur-
rence of a deletion that is identiﬁed as 13q minus syndrome
by using SKY only, but this does not reveal information
about the breakpoints. By simultaneously combining this
SKY-derived information with the banding patterns to be
tested, it can be diagnosed as a paracentric deletion with
breakpoints at q21.2 and q31.2. The karyotype of Case 2 is
described as 46,XX, der(2)t(2:4)(q24.2;p14)inv(4) (p15.
1p15.32), der(4)t(2;4), del(13)(q21.2q31.2) or 46,XX,t(2;4)
(q24.2;p14), del(13)(q21.2q31.2). As stated above, it is dif-
ﬁculttomakeadeﬁnitivediagnosisfromtheresultsofaSKY
analysis alone, and also one needs to be careful, because the
conventional method of G-band staining cannot be used
directly as a stand-alone substitute. Thus, more reliable
interpretation and diagnosis can be made by combining the
information from the two separate techniques, as neither of
them can be used for unequivocal diagnosis.
When performing tests using SKY, it is necessary to
understand the characteristics and the limitations of this
analysis, and to combine the test results with those of
G-band staining or high-resolution chromosome banding
for a comprehensive karyotypic diagnosis.
Conclusion
With the introduction of SKY, a new technology of chro-
mosome analysis, the accuracy of testing is improved and it
now becomes possible to devise new clinical studies that
previously had not been feasible with conventional testing
methods. T-Band regions such as 1p, 11p15, 16p, 19p, 19q,
and 22q are known as sites that are difﬁcult to observe as
bands of contrasting colors, even though it is believed that
these regions contain many genes, according to conven-
tional chromosome analysis. Furthermore, the macroscopic
analysis of that band with the human eye involves a limi-
tation in recognizing minor reciprocal translocations, and it
is also possible that they may go unnoticed. Identiﬁcation
via SKY coloring has overcome the weakness of the con-
ventional band pattern diagnosis method, and it is expected
that other previously unrecognized speciﬁc chromosomal
translocations are likely to be revealed with the widespread
use of this technique.
Moreover,inrecentyears,spectralcolorbandinghasbeen
developedasatechniquethathasovercomethelimitationsof
SKY [22] and in this technique G-band differential staining
is combined with the SKY coloring technology. Clinical use
of this novel technique is expected to be widespread in the
ﬁeld ofclinical genetics inthe future and tomake signiﬁcant
contributions. However, the cost of this technique still
remains prohibitory. Considering these points, from the
standpoint of genetic counseling, incorporation of SKY into
G-band chromosome banding or high-resolution chromo-
some banding as needed would be the most practical tech-
nique of chromosome testing. In fact, when the structural
abnormality of achromosome of unknown originisdetected
viaG-banding,thecombineduseofSKYmakesitpossibleto
identify the origin without performing karyotyping of the
parents, which could identify which parent is the carrier of
the balanced structural abnormality. Therefore, in the clini-
calpracticeofgeneticcounseling,informedconsentforatest
of congenital chromosomal abnormalities can be readily
obtainedfrom the parents.Furthermore, an evaluation of the
SKYresultsismadebasedonthecolorsthataredisplayed,so
itiseasyforaphysiciantoexplaintheresultstotheparentsof
a patient. This advantage could potentially reduce the
unnecessary psychological burden on parents with a child
whodemonstratesastructuralabnormalityinachromosome.
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Fig. 1 Chromosome analysis on Trisomy 11/22 using SKY
Fig. 2 Chromosome analysis of 13q-syndrome using SKY showing
structural abnormalities in chromosomes 2, 4, and 13
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